echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > "500 varieties" with volume procurement motivation speculation and situation discussion.

    "500 varieties" with volume procurement motivation speculation and situation discussion.

    • Last Update: 2020-08-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Wen . . . Code Wanxuan on the "500 varieties, to carry the volume of procurement" rumors, the main transmission of the following information: First, the main coverage, from 19 provinces to cover other provinces;
    so far, Beijing, Shanghai, Tianjin, Shaanxi, Shanxi, Hainan, Heilongjiang and other places have launched the non-selected drug gradient price reduction, these drugs have achieved the first round of price reduction nationwide.
    industry view that, excluding the 113 varieties harvested by the state, 387 varieties will be determined by the local procurement on a case-by-case basis.
    a list of online messages, the company has a total of trillions of sales.
    , including Changchun cetin, bone peptide injection type and other key monitoring drugs, as well as ritoxic, quentozo, bevadin monothesis and other biological agents.
    , the hole wind, for a while can not prove the source, but can still be analyzed: the necessity of the source and where feasibility.
    this article we downplay who meets, who lists, to speculate on the establishment of "500 varieties" or "600 varieties" motivation.
    , from the second half of the medical reform task to the steady establishment of a long-term mechanism in the second half of 2020 medical reform task came out, deepening the new medical reform breakthrough, the results of the work has been affirmed.
    the "500 varieties" transmitted online at this time, both market concerns, but also should become market determination.
    as long as the implementation of volume procurement continues to be one of the cattle noses to deepen the new medical reform, "500 varieties" must be on the work extension line, but the time is too late.
    "500 varieties" announced the three medical joint reform will be firm, strategic hammer tone, tactical and trial line, breakthrough in the determination.
    2, from the place where the pilot has been carried out think there is no way not to evaluate the drug has been a lot of local volume procurement, Qinghai and other places have included chinese medicine injection type of key monitoring varieties on hand.
    , several national anti-cancer drug negotiations have been able to attract exclusive varieties of drug economics mapping by way of an undetected approach.
    in the "500 varieties" before, it is said to be planning for traditional Chinese medicine, biologics with the amount of procurement, then thought difficult.
    but in less than a week, the puzzle seems to have become simpler than the blueprint for "500 varieties".
    as long as there is strategic support, there is no road on the ground can also open up new roads.
    been carried out in the local pilot has achieved a lot of results, the varieties involved have not yet risen to the national volume procurement level.
    every time the national volume procurement has a procurement cycle, drug prices are not reduced that time on the safety.
    "500 varieties" of the necessary significance lies not only in the expansion of varieties, but also in the holding of the quantity of purchased varieties into the spiral price reduction track of determination.
    Nity and local volume procurement pilot price reduction effect is like "sleet through the air, shock the shore, roll up a thousand piles of snow", can not let the snow pile has been maintained the status quo, "500 varieties" in a considerable number of varieties need to experience more than once snow removal round.
    3, from volume procurement to health insurance catalog and payment to complete a very limited number of exclusive varieties can become the national health insurance catalog negotiating varieties, which is an honor similar to the status of the base drug.
    once through this channel into the health insurance catalog, is also expected to be able to play an approximate role in the base drug.
    from the current situation, some through the national health insurance negotiations into the catalog of anti-cancer drugs, admission to the hospital release effect is not good.
    has since been approved for listing of biosynthic drugs are not included in the medical insurance, relying on pure market pricing, indirect drug-giving program to create an advantage, the environment is more embarrassing.
    from the "500 varieties", the national health insurance negotiations of the exclusive varieties can be affected by the volume of procurement.
    the future development of health care, whether it is the health insurance catalog, the base drug catalog, all emphasize dynamic adjustment.
    the wind and grass movement, with volume procurement is very suitable to take advantage of the opportunity to bridge.
    if there is no volume of procurement in front of the competitive price, health insurance catalog adjustment and payment standards formed without mature conditions, it is unstable and reliable.
    , said that under the three medical linkage, the industry can not clean up without scraping off the gold of biological agents and traditional Chinese medicine.
    4, from the focus of monitoring varieties to the two-sided role of volume procurement "500 varieties" why include key monitoring varieties? Band quantity procurement is still more respectful of market reality, such as Qinghai belt volume procurement on the chinese medicine injection type into the.
    A recent study suggested that enterprises in the situation of mass procurement, bigger and stronger peptide drugs, peptides in the thymus peptides, etc. have also been included in the focus of monitoring.
    us, the focus of monitoring seems to brake sharply, do not rule out the use of too hard, so that it can be immediate.
    a drug is reasonable and unreasonable, and ultimately the market will decide.
    but the market once, and now there was a partial failure, how to do? Then there is the focus of monitoring methods that have been done before, as well as the current and next few years as a forward with the volume procurement methods.
    Band volume procurement into the key monitoring varieties, the connotation shows three layers of seemingly contradictory but compatible reasons: First, in the way of administrative intervention, the strength of a moderate correction;
    with the volume of procurement for enterprises, is it good or bad? It is different for different varieties, and it is different for different enterprises under the same variety.
    the same enterprise in different periods to adopt different coping strategies, the results have been good or bad.
    this is because: the volume of procurement from the selection, bid to bid, sales, seemingly in the same situation of enterprises, varieties are always supportive and combat the two sides.
    nature of the strike, "500 varieties" is not allowed to strike only chemical generics that have been evaluated for consistency.
    from the nature of support, the revitalization of the pharmaceutical industry should also pay attention to the development of pharmaceutical, biological agents ah.
    some provinces have made the collection method clear to several ways, with volume procurement is only one of the immediate effect.
    then put forward a very realistic question: collection will be able to cover a full range of drugs (including traditional Chinese medicine, biological drugs, chemical drugs, etc.), with the amount of procurement is not yet able to, then how to do? So there may really be such a "500 varieties" list.
    you believe in me I believe in you, sincere is spiritual.
    back to the relationship between the focus on monitoring varieties and volume procurement, but also involves a matter of truth.
    that is: some key monitoring varieties may be gradually removed from the health insurance catalog, the key monitoring varieties are set by the head of the health department; The reason is: under the three medical linkage, some places, including the collection of goods with volume procurement has locked all the drugs in public hospitals, and a considerable proportion of private hospitals are in the scope of medical insurance fixed-point firepower.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.